(No ratings)
Dr. Prem K. Kamboj, MD is a pediatrician in Tulare, CA specializing in general pediatrics. He graduated from Government Medical College, Patiala. Dr. Prem K. Kamboj, MD is affiliated with Dignity Health.
Dr. Prem K. Kamboj, MD graduated from Government Medical College, Patiala. He completed residency at Raymond Blank Memorial Hospital. He has a state license in California.
Medical School: Government Medical College, Patiala
Residency: Raymond Blank Memorial Hospital
Licensed In: California
Dr. Prem K. Kamboj, MD is associated with these hospitals and organizations:
Dr. Prem K. Kamboj, MD does not have any reviews yet, be the first to leave a review of Dr. Prem K. Kamboj, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Prem K. Kamboj, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| SANOFI PASTEUR INC. |
$712
SKLICE $147 |
ADACEL $130 |
FLUZONE $108 |
FLUZONE QIV $107 |
QUADRACEL $100 |
Other $119 |
|---|---|---|---|---|---|---|
| Supernus Pharmaceuticals, Inc. |
$341
QELBREE $341 |
|||||
| Pfizer Inc. |
$329
QUILLIVANT XR $213 |
EUCRISA $66 |
GENOTROPIN $23 |
COMIRNATY $14 |
TRUMENBA $13 |
|
| Teva Pharmaceuticals USA, Inc. |
$314
QVAR $251 |
QNASL $63 |
||||
| Merck Sharp & Dohme Corporation |
$234
GARDASIL9 $156 |
ROTATEQ $44 |
VAXELIS $24 |
GARDASIL $10 |
||
| Other |
$1,454
Aerospan $144 |
ImmunoCAP $120 |
BEXSERO $99 |
JORNAY PM $93 |
BioTherapeutics - GAMMAGARD-KIOVIG $88 |
Other $909 |
| Food and Beverage | $3,312 |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $65 |
| Education | $7 |
Dr. Prem Kamboj's area of specialization is general pediatrics. In addition to English, Dr. Kamboj (or staff) speaks Hindi. Dr. Kamboj is affiliated with Dignity Health. He graduated from Government Medical College, Patiala. According to Dignity Health, Dr. Kamboj is not acceping new patients at this time.